LASITA M50

bt_bb_section_bottom_section_coverage_image
https://www.larivinpharma.com/wp-content/uploads/2024/04/LASITA-M50.jpg

Composition

Sitagliptin 50 mg & Metformin Prolonged Release 500 mg Tablets

Pack: 10 tablets/strip

Dosage:

  • Recommended Dose: One tablet twice daily, typically taken with meals to reduce the risk of gastrointestinal side effects.
  • Special Populations:
    • Renal Impairment: Dose adjustments may be necessary based on kidney function. Consult with a healthcare professional.
    • Hepatic Impairment: Use with caution; liver function should be monitored.
    • Elderly: Dose adjustments are generally not required, but monitoring of kidney function is advised.

Mode of Action:

  • Sitagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, which helps regulate blood glucose by enhancing insulin release and decreasing glucagon levels in a glucose-dependent manner.
  • Metformin Prolonged Release: A biguanide that reduces hepatic glucose production and improves insulin sensitivity, leading to better glycemic control. The prolonged-release formulation allows for steady absorption and reduces the incidence of gastrointestinal side effects.

Indication:

  • Management of Type 2 diabetes mellitus in adults, particularly in patients who require a combination of sitagliptin and metformin for improved glycemic control.

How to Take Lasita M50:

  • Take one tablet twice daily, with meals to minimize gastrointestinal side effects such as nausea and diarrhea.
  • Swallow the tablet whole with water. Do not crush or chew the tablet, as it is designed for prolonged release.
  • Maintain a consistent routine for taking the medication to ensure optimal blood glucose control.

Possible Side Effects:
As with any medication, Lasita M50 may cause side effects, although not everyone will experience them. Common side effects include:

  • Gastrointestinal Issues: Nausea, diarrhea, stomach pain, or indigestion, particularly when first starting the medication.
  • Hypoglycemia (Low Blood Sugar): More likely if combined with other antidiabetic medications. Symptoms may include dizziness, sweating, confusion, and shaking.
  • Upper Respiratory Tract Infections: Symptoms may include a sore throat, runny nose, or cough.
  • Headache: A common side effect that may decrease over time.
  • Joint Pain: Some patients may experience joint pain, which should be reported to a healthcare provider if severe.
  • Vitamin B12 Deficiency: Long-term use of metformin can lead to vitamin B12 deficiency, potentially causing anemia or neuropathy.
  • Pancreatitis: Rare but serious, symptoms include severe abdominal pain, nausea, and vomiting.

Precautions:

  • Renal Function: Regular monitoring is required, especially in patients with pre-existing kidney conditions.
  • Liver Function: Use with caution and monitor liver enzymes periodically.
  • Pancreatitis Risk: Be aware of the symptoms and seek immediate medical attention if they occur.
  • Lactic Acidosis: Although rare, metformin can cause lactic acidosis, a serious condition that requires immediate medical attention. Symptoms include rapid breathing, muscle pain, and severe weakness.
  • Allergic Reactions: Rarely, severe allergic reactions may occur. Seek medical attention if symptoms such as rash, itching, or swelling occur.

Consult Your Doctor:

  • Before starting Lasita M50 if you have any underlying medical conditions, particularly those affecting the kidneys, liver, or pancreas.
  • If you experience any unusual symptoms or side effects, especially signs of hypoglycemia or lactic acidosis.
  • For personalized advice on managing diabetes, including diet, exercise, and other lifestyle modifications.

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/LASITA-M50.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved